Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

tyrphostin AG 126

A member of the tyrphostin family of tyrosine kinase inhibitors, that actively blocks lipopolysaccharide-induced production of tumor necrosis factor… 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

AG 126
Receptor Tyrosine Kinase Inhibition

Broader (1)

Tyrphostins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat
In this study, we evaluated the effect of tyrphostin AG126, a tyrosine kinase inhibitor, in the splanchnic artery occlusion (SAO… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
Tyrphostin AG 126 inhibits development of postoperative ileus induced by surgical manipulation of murine colon.
Manipulation of the bowel during abdominal surgery leads to a period of ileus, which is most severely manifested after procedures… 
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2004
2004
Tyrosine Kinase Inhibition Reduces Inflammation in the Acute Stage of Experimental Pneumococcal Meningitis
ABSTRACT Bacterial meningitis is an acute inflammatory disease of the central nervous system with a mortality rate of up to 30… 
2002
2002
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat
AbstractObjective. To investigate the effects of tyrphostin AG 126, a tyrosine kinase inhibitor, on the multiple organ failure… 
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2000
2000
The Tyrosine Kinase Inhibitor Tyrphostin AG 126 Reduces the Development of Colitis in the Rat
Inflammatory bowel disease is characterized by oxidative and nitrosative stress, leukocyte infiltration, up-regulation of the… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1994
Highly Cited
1994
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors.
Septic shock results from excessive stimulation of the host immune system, especially macrophages, by lipopolysaccharide (LPS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE